A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Sumitomo Pharma America, Inc.
Pfizer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Laser Tissue Welding, Inc.
Vanquish Oncology, Inc.
Pfizer
Mauna Kea Technologies
Novartis